The Combined Effect of Triple Therapy With Rosiglitazone, Metformin, and Insulin Aspart in Type 2 Diabetic PatientsMikael Kjær Poulsen(Odense University Hospital), Henning Beck‐Nielsen(Odense University Hospital)Diabetes CareDecember 1, 200310.2337/diacare.26.12.3273Cited by 68SaveCiteExport RISWatch citationsRelated PapersPartial rescue of in vivo insulin signalling in skeletal muscle by impaired insulin clearance in heterozygous carriers of a mutation in the insulin receptor gene|Diabetologia|2006|24